The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.50
Bid: 68.00
Ask: 71.00
Change: 0.50 (0.72%)
Spread: 3.00 (4.412%)
Open: 68.00
High: 69.50
Low: 68.00
Prev. Close: 69.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Synbiosis Update

28 Jun 2010 07:00

RNS Number : 1395O
Scientific Digital Imaging Plc
28 June 2010
 



 

 

SCIENTIFIC DIGITAL IMAGING PLC

 

("SDI" or "The Group")

 

 

SYNBIOSIS INTRODUCES NEW IMAGING ACCESSORY, ProcUV,

AND

IMPROVEMENTS ARE MADE TO ProtoCOL2

 

SDI, the AIM quoted group focused on the needs of the scientific community, is pleased to update the market regarding recent developments at Synbiosis, a core division of SDI's principal subsidiary Synoptics Ltd. ("Synoptics"), a developer and manufacturer of innovative scientific instruments and systems that exploit digital imaging technology for a range of disciplines.

 

Highlights

 

·; ProtoCOL2 automated colony counter has been extensively tested to enable rapid, accurate counts of Legionella on any Legionella detection media

·; ProtoCOL2 upgraded to allow rapid statistical analysis of flu and bacterial vaccine potency and antibiotics susceptibility testing results

·; Synbiosis has introduced ProcUV, a new UV imaging accessory for the ProtoCOL2 system

 

 

At Synbiosis, the world-leading manufacturer of automated microbiological systems, the innovative ProtoCOL2 automated colony counter has been extensively tested by the Synbiosis technical team to enable rapid, accurate counts of Legionella on any Legionella detection media. The team found that by using the ProtoCOL2 system, 600Legionella plates could be accurately processed per hour, which is approximately 30 times more than can be achieved using traditional, time consuming, error-prone manual techniques.

 

The ProtoCOL2 has also been upgraded to allow rapid statistical analysis of flu and bacterial vaccine potency and antibiotics susceptibility testing results. The ProtoCOL2 software has also been upgraded so that numerical data can be automatically transferred into programmes for statistical analysis saving scientists valuable time and preventing transcription errors, as data can be transferred via a single button click rather than manually entered.

 

Additionally, Synbiosis has introduced ProcUV, its new ultra-violet imaging accessory for the ProtoCOL2 system. ProcUV permits instant imaging of fluorescent colonies and plaques so that they can be automatically counted or analysed by ProtoCOL2, thus saving time and improving accuracy of results.

 

ProcUV is simple to set up as its automatic exposure time settings ensure users can capture colony images at the touch of a button. The high-quality images can then be directly transferred into the ProtoCOL2 in seconds, where the ProtoCOL2 counts and analyses results automatically, to save microbiologists countless hours of repetitive work.

 

Commenting on the progress SDI's Chairman, Harry Tee, said:

 

"Synbiosis' progress with ProcUV and ProtoCOL2 demonstrates that we have risen to the challenge of rapid and accurate quantification of some of the most difficult-to-count colonies. We continue to look at new and innovative ways to improve our product offering to meet the needs of the scientific community."

 

 

 

--END--

 

 

FOR FURTHER INFORMATION

 

Scientific Digital Imaging plc 01223 727144

Harry Tee CBE, Chairman

Phil Atkin, CEO

www.scientificdigitalimaging.com 

 

Bishopsgate Communications 020 7562 3350

Gemma O'Hara

Siobhra Murphy

sdi@bishopsgatecommunications.com 

 

 

 

 

Note to Editors

 

 

Scientific Digital Imaging plc

 

SDI plc is focused on the application of digital imaging technology to the needs of the scientific community.

 

The principal subsidiary is Synoptics, which designs and manufactures special-purpose instruments for use in the life sciences. In October 2008 SDI acquired the entire share capital of Artemis and Perseu, companies (now known as "Atik") that design and manufacture high-sensitivity cameras for both astronomical and life sciences applications and whose products are used in instruments manufactured by Synoptics.

 

SDI, through its subsidiaries, offers a range of digital imaging solutions and intends to acquire other companies that are capable of contributing one or more key elements to the solutions required including an in-depth understanding of the applications in the marketplace, the ability to engineer complete systems to address such applications and the provision of key, high-performance components such as cameras.www.scientificdigitalimaging.com

 

 

Synoptics Ltd

 

Synoptics develops and manufactures innovative scientific instruments and systems that exploit digital imaging technology for a range of disciplines. Synoptics offers its products through 3 divisions.

 

·; Syngene - produces equipment for life scientists to image and analyse electrophoresis gels used for DNA and protein analysis.

·; Synbiosis - produces equipment for microbiologists to automate microbial colony counting.

·; Syncroscopy - provides systems which apply digital imaging techniques to microscopy applications, such as life and material sciences.

 

The Synoptics strategy is to deliver world-class, innovative products that satisfy the real needs of customers in science and industry. It does this by understanding their demands, and using its component technologies and skills in image processing and analysis to engineer appropriate solutions. The Company also seeks to exploit its unique technologies directly, by establishing OEM partnerships with other companies. www.synoptics.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZXLFLBQFXBBD
Date   Source Headline
19th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
13th Jan 20215:20 pmRNSExercise of Options and Total Voting Rights
12th Jan 20217:23 amRNSProgressive publishes new research
5th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
10th Dec 202010:20 amRNSDirector Dealing
10th Dec 20207:00 amRNSInvestor Presentation
9th Dec 20207:00 amRNSInterim Results
7th Dec 202011:06 amRNSSecond Price Monitoring Extn
7th Dec 202011:01 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSAcquisition of Monmouth Scientific Limited & TVR
26th Nov 20204:50 pmRNSExercise of Options and Total Voting Rights
28th Oct 20202:23 pmRNSChange of Website
22nd Oct 20207:00 amRNSTrading Update
23rd Sep 20202:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20202:00 pmRNSPrice Monitoring Extension
23rd Sep 202011:40 amRNSResult of AGM
23rd Sep 20207:00 amRNSAGM Trading Update & Investor Meet Company Q&A
3rd Sep 20204:24 pmRNSExercise of Options and Total Voting Rights
26th Aug 20204:49 pmRNSPosting of AR&A and Notice of AGM - Replacement
26th Aug 20204:11 pmRNSPosting of AR&A and Notice of AGM
17th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202010:51 amRNSDirector Dealing
21st Jul 20207:01 amRNSInvestor Presentation
21st Jul 20207:00 amRNSFinal Results
9th Jul 20207:00 amRNSNotice of Results
26th May 20202:06 pmRNSSecond Price Monitoring Extn
26th May 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSTrading & COVID-19 Update
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20203:10 pmRNSHolding(s) in Company
31st Jan 20201:19 pmRNSHolding(s) in Company
24th Jan 20203:29 pmRNSExercise of Options
27th Dec 20199:30 amRNSHolding(s) in Company
19th Dec 20191:14 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSAcquisition
31st Oct 20197:00 amRNSChange of Name
9th Oct 201910:43 amRNSExercise of Options
25th Sep 20194:55 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Update
20th Sep 20191:15 pmRNSDate of Annual General Meeting
3rd Sep 20195:46 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20197:04 amRNSDirector/PDMR Shareholding
18th Jul 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSTrading Update
15th May 20197:00 amRNSTrading Update
9th May 20197:00 amRNSSDI to present at Mello 2019
5th Apr 201911:02 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.